Listed

Maxcyte, Inc.

MXCTNasdaqCIK 1287098IndustrialsFiscal year ends Dec 31

Latest reported revenue, Q2 FY2026$4.9mRevenue, Q2 FY2026, three months to 2026-06-30$4.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-13, accession 0001104659-26-095971.Report this figureThree months to Jun 30, 2026, from the 10-Q filed Aug 13, 2026.

Latest quarter: Q2 FY2026

Three months to Jun 30, 2026, against the same quarter a year earlier.

  • Revenue$4.9mRevenue, Q2 FY2026, three months to 2026-06-30$4.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-13, accession 0001104659-26-095971.Report this figure−15.2% on a year earlier
  • Gross margin113.4%Gross margin, Q2 FY2026, three months to 2026-06-30. gross profit / revenueGross profit: $5.6m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-08-13, accession 0001104659-26-095971.Revenue: $4.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-13, accession 0001104659-26-095971.Report this figure−6.6 pts on a year earlier
  • Operating margin−207.3%Operating margin, Q2 FY2026, three months to 2026-06-30. operating income / revenueOperating income: −$10.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-13, accession 0001104659-26-095971.Revenue: $4.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-13, accession 0001104659-26-095971.Report this figure+37.0 pts on a year earlier
  • Net margin−179.8%Net margin, Q2 FY2026, three months to 2026-06-30. net income / revenueNet income: −$8.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-13, accession 0001104659-26-095971.Revenue: $4.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-13, accession 0001104659-26-095971.Report this figure+32.4 pts on a year earlier
  • Diluted EPS−$0.08Diluted EPS, Q2 FY2026, three months to 2026-06-30−$0.08 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-13, accession 0001104659-26-095971.Report this figure+33.3% on a year earlier
  • Free cash flow−$4.7mFree cash flow, Q2 FY2026, three months to 2026-06-30. operating cash flow − capital expenditureOperating cash flow: −$4.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-13, accession 0001104659-26-095971. Derived: 6-month figure less the 3-month figure.Capital expenditure: $62.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-13, accession 0001104659-26-095971. Derived: 6-month figure less the 3-month figure.Report this figure+54.7% on a year earlier

Last eight quarters

Full statements
Revenue$4.9mGross margin 113.4%
Diluted EPS−$0.08, Q2 FY2026
Free cash flow−$4.7m, Q2 FY2026
Maxcyte, Inc., key figures for the last eight quarters
Line itemUnitQ3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30Shape over the periods
Revenue$m5.6Revenue, Q3 FY2024, three months to 2024-09-30$5.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-13, accession 0001104659-25-111396.Report this figure6.1Revenue, Q4 FY2024, three months to 2024-12-31$6.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-25, accession 0001104659-26-034557. Derived: 12-month figure less the 9-month figure.Report this figure5.7Revenue, Q1 FY2025, three months to 2025-03-31$5.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-13, accession 0001104659-26-060290.Report this figure5.8Revenue, Q2 FY2025, three months to 2025-06-30$5.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-13, accession 0001104659-26-095971.Report this figure4.6Revenue, Q3 FY2025, three months to 2025-09-30$4.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-13, accession 0001104659-25-111396.Report this figure4.8Revenue, Q4 FY2025, three months to 2025-12-31$4.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-25, accession 0001104659-26-034557. Derived: 12-month figure less the 9-month figure.Report this figure4.5Revenue, Q1 FY2026, three months to 2026-03-31$4.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-13, accession 0001104659-26-060290.Report this figure4.9Revenue, Q2 FY2026, three months to 2026-06-30$4.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-13, accession 0001104659-26-095971.Report this figure
Gross margin%111.1%Gross margin, Q3 FY2024, three months to 2024-09-30. gross profit / revenueGross profit: $6.2m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-11-13, accession 0001104659-25-111396.Revenue: $5.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-13, accession 0001104659-25-111396.Report this figure105.9%Gross margin, Q4 FY2024, three months to 2024-12-31. gross profit / revenueGross profit: $6.4m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-03-25, accession 0001104659-26-034557. Derived: 12-month figure less the 9-month figure.Revenue: $6.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-25, accession 0001104659-26-034557. Derived: 12-month figure less the 9-month figure.Report this figure154.8%Gross margin, Q1 FY2025, three months to 2025-03-31. gross profit / revenueGross profit: $8.9m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-05-13, accession 0001104659-26-060290.Revenue: $5.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-13, accession 0001104659-26-060290.Report this figure120.0%Gross margin, Q2 FY2025, three months to 2025-06-30. gross profit / revenueGross profit: $7.0m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-08-13, accession 0001104659-26-095971.Revenue: $5.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-13, accession 0001104659-26-095971.Report this figure113.7%Gross margin, Q3 FY2025, three months to 2025-09-30. gross profit / revenueGross profit: $5.2m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-11-13, accession 0001104659-25-111396.Revenue: $4.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-13, accession 0001104659-25-111396.Report this figure118.9%Gross margin, Q4 FY2025, three months to 2025-12-31. gross profit / revenueGross profit: $5.7m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-03-25, accession 0001104659-26-034557. Derived: 12-month figure less the 9-month figure.Revenue: $4.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-25, accession 0001104659-26-034557. Derived: 12-month figure less the 9-month figure.Report this figure179.6%Gross margin, Q1 FY2026, three months to 2026-03-31. gross profit / revenueGross profit: $8.1m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-05-13, accession 0001104659-26-060290.Revenue: $4.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-13, accession 0001104659-26-060290.Report this figure113.4%Gross margin, Q2 FY2026, three months to 2026-06-30. gross profit / revenueGross profit: $5.6m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-08-13, accession 0001104659-26-095971.Revenue: $4.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-13, accession 0001104659-26-095971.Report this figure
Operating margin%(250.4%)Operating margin, Q3 FY2024, three months to 2024-09-30. operating income / revenueOperating income: −$14.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-13, accession 0001104659-25-111396.Revenue: $5.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-13, accession 0001104659-25-111396.Report this figure(213.1%)Operating margin, Q4 FY2024, three months to 2024-12-31. operating income / revenueOperating income: −$12.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-25, accession 0001104659-26-034557. Derived: 12-month figure less the 9-month figure.Revenue: $6.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-25, accession 0001104659-26-034557. Derived: 12-month figure less the 9-month figure.Report this figure(214.1%)Operating margin, Q1 FY2025, three months to 2025-03-31. operating income / revenueOperating income: −$12.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-13, accession 0001104659-26-060290.Revenue: $5.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-13, accession 0001104659-26-060290.Report this figure(244.3%)Operating margin, Q2 FY2025, three months to 2025-06-30. operating income / revenueOperating income: −$14.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-13, accession 0001104659-26-095971.Revenue: $5.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-13, accession 0001104659-26-095971.Report this figure(307.4%)Operating margin, Q3 FY2025, three months to 2025-09-30. operating income / revenueOperating income: −$14.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-13, accession 0001104659-25-111396.Revenue: $4.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-13, accession 0001104659-25-111396.Report this figure(234.5%)Operating margin, Q4 FY2025, three months to 2025-12-31. operating income / revenueOperating income: −$11.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-25, accession 0001104659-26-034557. Derived: 12-month figure less the 9-month figure.Revenue: $4.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-25, accession 0001104659-26-034557. Derived: 12-month figure less the 9-month figure.Report this figure(137.4%)Operating margin, Q1 FY2026, three months to 2026-03-31. operating income / revenueOperating income: −$6.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-13, accession 0001104659-26-060290.Revenue: $4.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-13, accession 0001104659-26-060290.Report this figure(207.3%)Operating margin, Q2 FY2026, three months to 2026-06-30. operating income / revenueOperating income: −$10.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-13, accession 0001104659-26-095971.Revenue: $4.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-13, accession 0001104659-26-095971.Report this figure
Net margin%(205.9%)Net margin, Q3 FY2024, three months to 2024-09-30. net income / revenueNet income: −$11.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-13, accession 0001104659-25-111396.Revenue: $5.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-13, accession 0001104659-25-111396.Report this figure(175.0%)Net margin, Q4 FY2024, three months to 2024-12-31. net income / revenueNet income: −$10.6m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-25, accession 0001104659-26-034557. Derived: 12-month figure less the 9-month figure.Revenue: $6.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-25, accession 0001104659-26-034557. Derived: 12-month figure less the 9-month figure.Report this figure(178.7%)Net margin, Q1 FY2025, three months to 2025-03-31. net income / revenueNet income: −$10.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-13, accession 0001104659-26-095971.Revenue: $5.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-13, accession 0001104659-26-060290.Report this figure(212.2%)Net margin, Q2 FY2025, three months to 2025-06-30. net income / revenueNet income: −$12.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-13, accession 0001104659-26-095971.Revenue: $5.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-13, accession 0001104659-26-095971.Report this figure(269.7%)Net margin, Q3 FY2025, three months to 2025-09-30. net income / revenueNet income: −$12.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-13, accession 0001104659-25-111396.Revenue: $4.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-13, accession 0001104659-25-111396.Report this figure(200.5%)Net margin, Q4 FY2025, three months to 2025-12-31. net income / revenueNet income: −$9.6m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-25, accession 0001104659-26-034557. Derived: 12-month figure less the 9-month figure.Revenue: $4.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-25, accession 0001104659-26-034557. Derived: 12-month figure less the 9-month figure.Report this figure(105.5%)Net margin, Q1 FY2026, three months to 2026-03-31. net income / revenueNet income: −$4.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-13, accession 0001104659-26-095971.Revenue: $4.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-13, accession 0001104659-26-060290.Report this figure(179.8%)Net margin, Q2 FY2026, three months to 2026-06-30. net income / revenueNet income: −$8.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-13, accession 0001104659-26-095971.Revenue: $4.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-13, accession 0001104659-26-095971.Report this figure
Diluted EPS$ per share(0.11)Diluted EPS, Q3 FY2024, three months to 2024-09-30−$0.11 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-13, accession 0001104659-25-111396.Report this figurenot reported (Diluted EPS not reported)(0.10)Diluted EPS, Q1 FY2025, three months to 2025-03-31−$0.10 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-13, accession 0001104659-26-060290.Report this figure(0.12)Diluted EPS, Q2 FY2025, three months to 2025-06-30−$0.12 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-13, accession 0001104659-26-095971.Report this figure(0.12)Diluted EPS, Q3 FY2025, three months to 2025-09-30−$0.12 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-13, accession 0001104659-25-111396.Report this figurenot reported (Diluted EPS not reported)(0.04)Diluted EPS, Q1 FY2026, three months to 2026-03-31−$0.04 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-13, accession 0001104659-26-060290.Report this figure(0.08)Diluted EPS, Q2 FY2026, three months to 2026-06-30−$0.08 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-13, accession 0001104659-26-095971.Report this figure
Free cash flow$m(4.8)Free cash flow, Q3 FY2024, three months to 2024-09-30. operating cash flow − capital expenditureOperating cash flow: −$4.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-13, accession 0001104659-25-111396. Derived: 9-month figure less the 6-month figure.Capital expenditure: $406.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-13, accession 0001104659-25-111396. Derived: 9-month figure less the 6-month figure.Report this figure(8.0)Free cash flow, Q4 FY2024, three months to 2024-12-31. operating cash flow − capital expenditureOperating cash flow: −$7.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-25, accession 0001104659-26-034557. Derived: 12-month figure less the 9-month figure.Capital expenditure: $147.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-25, accession 0001104659-26-034557. Derived: 12-month figure less the 9-month figure.Report this figure(15.1)Free cash flow, Q1 FY2025, three months to 2025-03-31. operating cash flow − capital expenditureOperating cash flow: −$14.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-13, accession 0001104659-26-060290.Capital expenditure: $653.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-13, accession 0001104659-26-060290.Report this figure(10.4)Free cash flow, Q2 FY2025, three months to 2025-06-30. operating cash flow − capital expenditureOperating cash flow: −$9.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-13, accession 0001104659-26-095971. Derived: 6-month figure less the 3-month figure.Capital expenditure: $584.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-13, accession 0001104659-26-095971. Derived: 6-month figure less the 3-month figure.Report this figure(7.8)Free cash flow, Q3 FY2025, three months to 2025-09-30. operating cash flow − capital expenditureOperating cash flow: −$7.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-13, accession 0001104659-25-111396. Derived: 9-month figure less the 6-month figure.Capital expenditure: $300.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-13, accession 0001104659-25-111396. Derived: 9-month figure less the 6-month figure.Report this figure(2.9)Free cash flow, Q4 FY2025, three months to 2025-12-31. operating cash flow − capital expenditureOperating cash flow: −$2.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-25, accession 0001104659-26-034557. Derived: 12-month figure less the 9-month figure.Capital expenditure: $231.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-25, accession 0001104659-26-034557. Derived: 12-month figure less the 9-month figure.Report this figure(8.2)Free cash flow, Q1 FY2026, three months to 2026-03-31. operating cash flow − capital expenditureOperating cash flow: −$8.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-13, accession 0001104659-26-060290.Capital expenditure: $72.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-13, accession 0001104659-26-060290.Report this figure(4.7)Free cash flow, Q2 FY2026, three months to 2026-06-30. operating cash flow − capital expenditureOperating cash flow: −$4.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-13, accession 0001104659-26-095971. Derived: 6-month figure less the 3-month figure.Capital expenditure: $62.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-13, accession 0001104659-26-095971. Derived: 6-month figure less the 3-month figure.Report this figure

Focus or hover a figure to see its XBRL concept, period and filing; each links to that filing. A figure marked d is derived: a quarter computed from year-to-date figures, such as the fourth quarter as the fiscal year less the nine months before it. A ratio reads not reported when any input is missing.

Last five fiscal years

Revenue$21.0mGross margin 127.9%
Diluted EPS−$0.42, FY2025
Free cash flow−$36.2m, FY2025
Maxcyte, Inc., key figures for the last five fiscal years
Line itemUnitFY20212021-12-31FY20222022-12-31FY20232023-12-31FY20242024-12-31FY20252025-12-31Shape over the periods
Revenue$m21.6Revenue, FY2021, twelve months to 2021-12-31$21.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2023-03-15, accession 0001558370-23-003911.Report this figure28.7Revenue, FY2022, twelve months to 2022-12-31$28.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2024-03-12, accession 0001558370-24-003001.Report this figure19.5Revenue, FY2023, twelve months to 2023-12-31$19.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-03-11, accession 0001558370-25-002721.Report this figure22.2Revenue, FY2024, twelve months to 2024-12-31$22.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-25, accession 0001104659-26-034557.Report this figure21.0Revenue, FY2025, twelve months to 2025-12-31$21.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-25, accession 0001104659-26-034557.Report this figure
Gross margin%140.2%Gross margin, FY2021, twelve months to 2021-12-31. gross profit / revenueGross profit: $30.2m. XBRL concept us-gaap:GrossProfit. 10-K filed 2023-03-15, accession 0001558370-23-003911.Revenue: $21.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2023-03-15, accession 0001558370-23-003911.Report this figure136.2%Gross margin, FY2022, twelve months to 2022-12-31. gross profit / revenueGross profit: $39.2m. XBRL concept us-gaap:GrossProfit. 10-K filed 2024-03-12, accession 0001558370-24-003001.Revenue: $28.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2024-03-12, accession 0001558370-24-003001.Report this figure187.4%Gross margin, FY2023, twelve months to 2023-12-31. gross profit / revenueGross profit: $36.5m. XBRL concept us-gaap:GrossProfit. 10-K filed 2025-03-11, accession 0001558370-25-002721.Revenue: $19.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-03-11, accession 0001558370-25-002721.Report this figure141.9%Gross margin, FY2024, twelve months to 2024-12-31. gross profit / revenueGross profit: $31.5m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-03-25, accession 0001104659-26-034557.Revenue: $22.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-25, accession 0001104659-26-034557.Report this figure127.9%Gross margin, FY2025, twelve months to 2025-12-31. gross profit / revenueGross profit: $26.8m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-03-25, accession 0001104659-26-034557.Revenue: $21.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-25, accession 0001104659-26-034557.Report this figure
Operating margin%(84.3%)Operating margin, FY2021, twelve months to 2021-12-31. operating income / revenueOperating income: −$18.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2023-03-15, accession 0001558370-23-003911.Revenue: $21.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2023-03-15, accession 0001558370-23-003911.Report this figure(95.2%)Operating margin, FY2022, twelve months to 2022-12-31. operating income / revenueOperating income: −$27.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2024-03-12, accession 0001558370-24-003001.Revenue: $28.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2024-03-12, accession 0001558370-24-003001.Report this figure(247.7%)Operating margin, FY2023, twelve months to 2023-12-31. operating income / revenueOperating income: −$48.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-03-11, accession 0001558370-25-002721.Revenue: $19.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-03-11, accession 0001558370-25-002721.Report this figure(230.5%)Operating margin, FY2024, twelve months to 2024-12-31. operating income / revenueOperating income: −$51.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-25, accession 0001104659-26-034557.Revenue: $22.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-25, accession 0001104659-26-034557.Report this figure(247.6%)Operating margin, FY2025, twelve months to 2025-12-31. operating income / revenueOperating income: −$51.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-25, accession 0001104659-26-034557.Revenue: $21.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-25, accession 0001104659-26-034557.Report this figure
Net margin%(88.5%)Net margin, FY2021, twelve months to 2021-12-31. net income / revenueNet income: −$19.1m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2023-03-15, accession 0001558370-23-003911.Revenue: $21.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2023-03-15, accession 0001558370-23-003911.Report this figure(82.0%)Net margin, FY2022, twelve months to 2022-12-31. net income / revenueNet income: −$23.6m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2024-03-12, accession 0001558370-24-003001.Revenue: $28.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2024-03-12, accession 0001558370-24-003001.Report this figure(194.5%)Net margin, FY2023, twelve months to 2023-12-31. net income / revenueNet income: −$37.9m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-03-11, accession 0001558370-25-002721.Revenue: $19.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-03-11, accession 0001558370-25-002721.Report this figure(184.8%)Net margin, FY2024, twelve months to 2024-12-31. net income / revenueNet income: −$41.1m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-25, accession 0001104659-26-034557.Revenue: $22.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-25, accession 0001104659-26-034557.Report this figure(213.0%)Net margin, FY2025, twelve months to 2025-12-31. net income / revenueNet income: −$44.6m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-25, accession 0001104659-26-034557.Revenue: $21.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-25, accession 0001104659-26-034557.Report this figure
Diluted EPS$ per share(0.21)Diluted EPS, FY2021, twelve months to 2021-12-31−$0.21 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2023-03-15, accession 0001558370-23-003911.Report this figure(0.23)Diluted EPS, FY2022, twelve months to 2022-12-31−$0.23 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2024-03-12, accession 0001558370-24-003001.Report this figure(0.37)Diluted EPS, FY2023, twelve months to 2023-12-31−$0.37 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2025-03-11, accession 0001558370-25-002721.Report this figure(0.39)Diluted EPS, FY2024, twelve months to 2024-12-31−$0.39 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-03-25, accession 0001104659-26-034557.Report this figure(0.42)Diluted EPS, FY2025, twelve months to 2025-12-31−$0.42 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-03-25, accession 0001104659-26-034557.Report this figure
Free cash flow$m(14.5)Free cash flow, FY2021, twelve months to 2021-12-31. operating cash flow − capital expenditureOperating cash flow: −$10.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2023-03-15, accession 0001558370-23-003911.Capital expenditure: $3.8m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2023-03-15, accession 0001558370-23-003911.Report this figure(33.3)Free cash flow, FY2022, twelve months to 2022-12-31. operating cash flow − capital expenditureOperating cash flow: −$14.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2024-03-12, accession 0001558370-24-003001.Capital expenditure: $18.5m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2024-03-12, accession 0001558370-24-003001.Report this figure(25.4)Free cash flow, FY2023, twelve months to 2023-12-31. operating cash flow − capital expenditureOperating cash flow: −$21.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-03-11, accession 0001558370-25-002721.Capital expenditure: $3.7m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2025-03-11, accession 0001558370-25-002721.Report this figure(29.3)Free cash flow, FY2024, twelve months to 2024-12-31. operating cash flow − capital expenditureOperating cash flow: −$27.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-25, accession 0001104659-26-034557.Capital expenditure: $1.7m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-25, accession 0001104659-26-034557.Report this figure(36.2)Free cash flow, FY2025, twelve months to 2025-12-31. operating cash flow − capital expenditureOperating cash flow: −$34.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-25, accession 0001104659-26-034557.Capital expenditure: $1.8m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-25, accession 0001104659-26-034557.Report this figure

Focus or hover a figure to see its XBRL concept, period and filing; each links to that filing. A figure marked d is derived: a quarter computed from year-to-date figures, such as the fourth quarter as the fiscal year less the nine months before it. A ratio reads not reported when any input is missing.

Insider purchases and sales

All insider transactions

The last 20 open-market transactions reported on Form 4 (codes P and S). The reported price is the price per share the insider stated on the form: filing data, not a market price.

No open-market purchases or sales by insiders are in coverage from Nov 2024 to Oct 2026.

No open-market purchases or sales by insiders are in coverage for this company.

Funds that report holding it

All funds

From each manager's latest Form 13F, largest reported value first. Reported value is as filed at the quarter end: filing data, not a price. A put or call is an option position, not shares held.

Funds that report holding Maxcyte, Inc.
FundQuarter endedReported valueSharesPut or callChange on the quarter before
Capricorn Fund Managers Ltd2026-06-30$10.1m8,200,000Unchanged
Vitruvian Partners LLP2026-06-30$6.2m5,043,356Unchanged
VANGUARD CAPITAL MANAGEMENT LLC2026-06-30$5.0m4,031,284Added+49,468
MORGAN STANLEY2026-06-30$4.5m3,694,049Added+5,918
Mudita Advisors LLP2026-06-30$4.1m3,370,689Unchanged
BlackRock, Inc.2026-06-30$3.8m3,060,960Reduced−5,737,513
Brooklands Fund Management Ltd2026-06-30$3.7m2,848,083Added+658,063
BNP PARIBAS ASSET MANAGEMENT Holding S.A.2026-06-30$3.4m2,773,554Unchanged
CADIAN CAPITAL MANAGEMENT, LP2026-06-30$2.7m2,201,166Added+478,224
Peapod Lane Capital LLC2026-06-30$2.6m2,125,752Added+793,559

Recent filings

All 324 filings

Reports and events: 10-K, 10-Q, 8-K, proxy statements and ownership schedules.

Maxcyte, Inc., recent filings
FiledFormWhat it isAccession number
2026-10-1513:00 ETSCHEDULE 13DOwnership report, active investor0001544204-26-000009
2026-10-1412:10 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001104659-26-115745
2026-08-1320:32 ET10-QQuarterly reportPeriod 2026-06-300001104659-26-095971
2026-08-1220:14 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001104659-26-094886
2026-08-0412:42 ETSCHEDULE 13DOwnership report, active investor0001486180-26-000003
2026-06-1720:59 ET8-K5.07 Shareholder vote results0001104659-26-075211
2026-06-1620:21 ET8-K3.01 Delisting notice0001104659-26-074594
2026-05-1413:44 ETSCHEDULE 13DOwnership report, active investor0001486180-26-000002
2026-05-1320:31 ET10-QQuarterly reportPeriod 2026-03-310001104659-26-060290
2026-05-1220:12 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001104659-26-059399

Latest annual report

Form 10-K for the fiscal year ended Dec 31, 2025Filed Mar 25, 2026. Its page lists the documents and the extracted sections, such as Business and Risk factors.

Forecast league

Not in this season’s league. The league lists companies whose quarter has ended and whose results are not yet filed.This season’s league

About the filer

CIK
1287098
Tickers
MXCT
Exchange
Nasdaq
SIC code
8731 Services-Commercial Physical & Biological Research
Sector
Industrials
Fiscal year ends
Dec 31
Incorporated in
DE
Filer category
<br>Emerging growth company
Former names
MAXCYTE INC (to 2008-09-18)

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:36 ET. Listed shows no prices and gives no investment advice.